Klebsiella pneumoniae antimicrobial drug resistance, United States, 1998-2010

Emerging Infectious Diseases

Volumn 19, Issue 1, 2013, Pages 133-136

  Sanchez, Guillermo V ^a   Master, Ronald N ^b   Clark, Richard B ^b   Fyyaz, Madiha ^c   Duvvuri, Padmaraj ^c   Ekta, Gupta ^c   Bordon, Jose ^c  

^a GEORGE WASHINGTON UNIVERSITY   (United States)

^b QUEST DIAGNOSTICS NICHOLS INSTITUTE   (United States)

^c Providence Hospital   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMIKACIN; AZTREONAM; CARBAPENEM; CEFEPIME; CEFTAZIDIME; CIPROFLOXACIN; COTRIMOXAZOLE; IMIPENEM; PIPERACILLIN PLUS TAZOBACTAM; TETRACYCLINE; TIGECYCLINE; TOBRAMYCIN;

ANTIBIOTIC RESISTANCE; ARTICLE; CROSS RESISTANCE; DISEASE SURVEILLANCE; HUMAN; KLEBSIELLA PNEUMONIAE; NONHUMAN; PREVALENCE; UNITED STATES;

ANTI-BACTERIAL AGENTS; DRUG RESISTANCE, MULTIPLE, BACTERIAL; EPIDEMIOLOGICAL MONITORING; HUMANS; INPATIENTS; KLEBSIELLA INFECTIONS; KLEBSIELLA PNEUMONIAE; LONGITUDINAL STUDIES; MICROBIAL SENSITIVITY TESTS; RETROSPECTIVE STUDIES; UNITED STATES;

EID: 84871635409     PISSN: 10806040     EISSN: 10806059     Source Type: Journal    
DOI: 10.3201/eid1901.120310     Document Type: Article

References (15)

1. Won SY, Munoz-Pricc LS, Lolans K, Hola B, Weinstein RA, Hayden MK, et al. Emergence and rapid regional spread of Klebsiella pneumoniae carbapenemase-producing Enterobacteriaceae. Clin Infect Dis. 2011;53:532-40. http://dx.doi.org/10.1093/cid/cir482
2. Schwaber MJ, Carmeli Y. Carbapcncm-rcsislant Enterobacteriaceae'. a potential threat. JAMA. 2008;300:2911-3. http://dx.doi. org/10.1001 /jama.2008.896
3. Naas T, Nordmann P, Vedel G, Poyart C. Plasmid-mediated carbapenem-hydrolyzing bcla-laclamase KPC in a Klebsiella pneumoniae isolate from France. Antimicrob Agents Chemother. 2005;49:4423-4. http://dx.doi.Org/10.l 128/AAC.49.10.4423-4424. 2005
4. Rossi F, Baquero F, Hstieh P-R, Paterson DL, Bochicchio GV, Snyder TA, et al. In vitro susceptibilities of aerobic and facultatively anaerobic gram-negative bacilli isolated from patients with intraabdominal infections worldwide: 2004 results from SMART (Study for Monitoring Antimicrobial Resistance Trends). J Antimicrob Chemother. 2006;58:205-10. http://dx.doi.org/l 0.1093/jac/dkl 199
5. Sanchez GV, Master RN, Karlowsky JA, Bordon JM. In vitro antimicrobial resistance of urinary coli among U.S. outpatients from 2000 to 2010. Antimicrob Agents Chemother. 2012:56:2181-3. http://dx.doi.org/10.1128/AAC.06060-11
6. Sahm DF, Marsilio MK, Piazza G. Antimicrobial resistance in key bloodstream bacterial isolates: electronic surveillance with the Surveillance Network Database-USA. Clin Infect Dis. 1999:29:259-63. http://dx.doi.org/l 0.1086/520195
7. Bratu S, Mooty M, Nichani S, Landman D, Gullans C, Petlinalo B, et al. Emergence of KPC-possessing Klebsiella pneumoniae in Brooklyn, New York: epidemiology and recommendations for detection. Antimicrob Agents Chemother. 2005;49:3018-20. http:// dx.doi.org/10.1128/AAC49.7.3018-3020.2005
8. Rhomberg PR, Jones RN. Summary trends for the Meropenem Yearly Susceptibility Test Information Collection Program: a 10-year experience in the United States (1999-2008). Diagn Microbiol Infect Dis. 2009;65:414-26. http://dx.doi.org/lO.lOl6/j. diagmicrobio.2009.08.020
9. Centers for Disease Control and Prevention. Guidance for control of infections with carbapenem-resistant or carbapenemase-producing Enterobacteriaceae in acute care facilities. MMWR Morb Mortal Wkly Rep. 2009;58:256-60.
10. Agwuh KN, MacGowan A. Pharmacokinetics and pharmacodynamics of the tetracyclines including glycylcyclines. J Antimicrob Chemother. 2006;58:256-65. http://dx.doi.org/10.1093/jac/dkl224
11. Poulakou G, Kontopidou FV, Paramythiotou E, Kompoti M, Katsiari M, Mainas E, et al. Tigecycline in the treatment of infections from multi-drug resistant gram-negative pathogens. J Infect. 2009;58:273-84. http://dx.doi.Org/10.1016/j.jinf.2009.02.009
12. Humphries RM, Kelesidis T, Dien Bard J, Ward KW, Bhattacharya D, Lewinski MA. Successful treatment of pan-resistant Klebsiella pneumoniae pneumonia and bacteraemia with a combination of high-dose tigecycline and colistin. J Med Microbiol. 2010;59:1383-6. http://dx.doi.Org/10.1099/jmm.0.023010-0
13. Kitchel B, Sundin DR, Patel JB. Regional dissemination of KPC-producing Klebsiella pneumoniae. Antimicrob Agents Chemother. 2009;53:4511-3. http://dx.doi.org/10.1128/AAC.00784-09
14. Gupta N, Limbago BM, Patel JB, Kallen AJ. Carbapenem-resistant Enterobacteriaceae: epidemiology and prevention. Clin Infect Dis. 2011;53:60-7. http://dx.doi.org/l 0.1093/cid/cir202
15. Spellberg B, Guidos R, Gilbert D, Bradley J, Boucher HW, Scheld WM, et al. The epidemic of antibiotic-resistant infections: a call to action for the medical community from the Infectious Diseases Society of America. Clin Infect Dis. 2008;46:155-64. http://dx.doi. org/10.1086/524891